Browsing "Obstetrics & Gynaecology: Conference papers" by Author rp00543

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 18 to 37 of 97 < previous   next >
TitleAuthor(s)Issue DateViews
 
2008
 
Functional analysis of the alpha-2 subunit of AMP-activated protein kinase in ovarian cancer
Proceeding/Conference:Conference of the Association for International Cancer Research, AICR 2010
2010
 
Functional analysis of the beta- 1 sununit of AMP-activated protein kinase in ovarian cancer
Proceeding/Conference:Research Postgraduate Symposium, RPS 2010
2010
97
 
Functional Analysis of the beta-1 sununit of AMP-activated Protein Kinase in Ovarian Cancer
Proceeding/Conference:HKICC 2010 & 4th Cross Strait Symposium on Pediatric Oncology
2010
69
Functional analysis of the β1 subunit of AMP-activated protein kinase in ovarian cancer
Proceeding/Conference:Annual Meeting of the American Association for Cancer Research, AACR 2010
2010
 
2009
173
 
Functional characterization of GRB7 and its variant, GRB7v, in ovarian cancer
Proceeding/Conference:Research Postgraduate Symposium, RPS 2008
2008
96
 
2011
 
2016
 
2009
 
Functional characterization of the novel bioactive protein from bitter melon (Momordica charantia) in combating ovarian cancer oncogenesis and chemoresistance
Proceeding/Conference:Academic Seminar, the Macau Institute For Applied Research in Medicine and Health, Macau University of Science and Technology (MUST)
2019
 
GRO-α and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1/NFκB signaling cascade
Proceeding/Conference:Cold Spring Harbour Asia Conference on Inflammation: Basic Mechanisms & Relevant Diseases
2017
 
Has-miR-141 plays a crucial role in ovarian cancer metastatic progression
Proceeding/Conference:HKU O & G 90th Anniversary Celebration Symposium
2015
66
 
Has-miR-141/KLF12/Survivin is a crtical pathway required for enhancing anoikis resistance of advanced ovarian cancer
Proceeding/Conference:CSHAsia 2015 Conference on Targeting Cell Death Mechanisms for the Treatment of Human Diseases
2015
64
 
2007
118
 
2014
35
 
2015
50
 
Identification of DLX1 as a FOXM1 downstream target in mediating ovarian cancer oncogenesis
Proceeding/Conference:Hong Kong International Cancer Congress, HKICC 2011
2011
 
2016
82
 
1997
132